BridgeBio Pharma Inc
NASDAQ:BBIO
BridgeBio Pharma Inc
NASDAQ:BBIO
Price:
66.97
USD
1.25%
Market Closed
Market Cap:
$13.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
NVIDIA Corp
SIX:NVDA
|
US |
|
E
|
Encompass Health Corp
F:HSOA
|
US |
|
B
|
Berkshire Hathaway Inc
XMUN:BRYN
|
US |
|
Cikarang Listrindo Tbk PT
IDX:POWR
|
ID |
|
N
|
Netcall PLC
F:NEW
|
UK |
|
Nintendo Co Ltd
LSE:0K85
|
JP |
|
D
|
Dolmen City REIT
KAR:DCR
|
PK |
|
C
|
China Petroleum & Chemical Corp
SWB:CHU
|
CN |
|
P
|
Pitney Bowes Inc
F:PBW
|
US |
|
RS Group PLC
LSE:RS1
|
UK |
|
F
|
Fermi Inc
NASDAQ:FRMI
|
US |
|
5G Networks Ltd
ASX:5GN
|
AU |
|
GSK plc
BMV:GSKN
|
UK |
|
W
|
Westar Oil & Gas Inc
OTC:TEXG
|
US |
|
M
|
Mondelez International Inc
XHAM:KTF
|
US |
|
F
|
Fagron NV
SWB:4A5
|
BE |
|
WH Group Ltd
HKEX:288
|
HK |
|
Bionime Corp
TWSE:4737
|
TW |
Multiples-Based Value
The Multiples-Based Value for BridgeBio Pharma Inc (BBIO) under the Base Case is hidden
USD.
Compared with the current market price of 66.97 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BBIO Multiples-Based Value
LOCKED